Severe adverse cardiovascular effects of pulse steroid therapy: Is continuous cardiac monitoring necessary?
- 31 May 1994
- journal article
- review article
- Published by Elsevier
- Vol. 30 (5) , 768-773
- https://doi.org/10.1016/s0190-9622(08)81508-3
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Successful treatment of aggressive pyoderma gangrenosum with pulse steroids and chlorambucilJournal of the American Academy of Dermatology, 1992
- Pyoderma gangrenosum associated with systemic lupus erythematosus: Response to pulse steroid therapyJournal of the American Academy of Dermatology, 1991
- Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.BMJ, 1990
- Lupus Nephritis: Efficacy of Monthly Pulse Therapy With Intravenous MethylprednisoloneSouthern Medical Journal, 1989
- Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprineArchives of Dermatology, 1988
- Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis: Report of a patient treated with corticosteroid “pulse therapy”Journal of the American Academy of Dermatology, 1985
- A dermatitis-eosinophilia syndrome. Treatment with methylprednisolone pulse therapyArchives of Dermatology, 1984
- PULSE METHYLPREDNISOLONE THERAPYThe Lancet, 1983
- EFFECTS OF HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE ON CIRCULATION IN HUMANSTransplantation, 1983
- Intermittent megadose corticosteroid therapy for generalized lichen planusJournal of the American Academy of Dermatology, 1982